BioSig Technologies, Inc. STEX Indefinite-Lived Research and Development Assets
Indefinite-Lived Research and Development Assets at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment.
The official record: BioSig Technologies, Inc.’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s indefinite-lived research and development assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s indefinite-lived research and development assets?
- BioSig Technologies, Inc. (STEX) reported indefinite-lived research and development assets of $562K in Q4 2024.
- What does indefinite-lived research and development assets mean?
- These are acquired research and development assets that have not yet reached technological feasibility and are therefore not subject to periodic amortization. They represent the company's investment in future innovation and long-term product pipeline growth. Investors monitor these assets to gauge the potential for future competitive advantages and the success of the company's R&D strategy.